Korean College of Rheumatology Biologics and Targeted Therapy Registry

RecruitingOBSERVATIONAL
Enrollment

10,000

Participants

Timeline

Start Date

December 1, 2012

Primary Completion Date

December 31, 2029

Study Completion Date

June 30, 2030

Conditions
Rheumatoid ArthritisAnkylosing SpondylitisPsoriatic Arthritis
Interventions
DRUG

Biologic or targeted synthetic DMARD

Trial Locations (1)

07061

RECRUITING

Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER